又一家医药CXO企业预计2025业绩翻倍,将大幅增超214%

制药网
Jan 21

根据梳理,1月20日晚间,誉衡药业与昭衍新药相继披露2025年度业绩预告,双双交出增长答卷。其中昭衍新药净利润同比增幅超214%,誉衡药业增幅也达50%以上。叠加此前药明康德的业绩亮眼表现,医药行业尤其是CXO板块复苏态势渐显,成为资本市场关注焦点。根据昭衍新药1月20日晚间发布的2025年度业绩预告显示,公司预计2025年归属净利润约2.33亿元到3.49亿元,同比增加约214%到371%。对于...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10